4.5 Article

Sporadic and Familial Adenomatous Polyposis-associated Foveolar-type Adenoma of the Stomach

期刊

AMERICAN JOURNAL OF SURGICAL PATHOLOGY
卷 47, 期 1, 页码 91-101

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PAS.0000000000001949

关键词

gastric foveolar-type adenoma; familial adenomatous polyposis; APC; KRAS

向作者/读者索取更多资源

Gastric foveolar-type adenoma (FA) is a rare benign neoplasm that can either occur sporadically or in patients with familial adenomatous polyposis (FAP). This study aimed to investigate the molecular features of FA and the relationship between sporadic and syndromic lesions. The results showed that sporadic FA includes at least two morphologically and genetically distinct subtypes: flat and raspberry-like FA. Additionally, it was found that flat FA represents a sporadic counterpart of FAP-associated FA.
Gastric foveolar-type adenoma (FA) is a rare benign neoplasm occurring either sporadically or in patients with familial adenomatous polyposis (FAP). However, the molecular features of FA and the relationship between sporadic and syndromic lesions remain unclear. In this study, we performed clinicopathological, immunohistochemical, and genetic analyses of 18 sporadic and 30 FAP-associated FAs. Most sporadic and FAP-associated FAs were located in the upper or middle third of the stomach, on a background of fundic gland mucosa. Most lesions were low-grade, but 3 lesions had a high-grade component. Sporadic FAs included 2 morphologically distinct subtypes, that is, flat and raspberry-like FAs, which we distinguished based on the endoscopic features. Seven lesions were regarded as flat FAs, appearing as large, slightly elevated lesions and measuring 11 to 87 mm in size. Conversely, 10 raspberry-like FAs were small bright-red polyps, measuring 2 to 8 mm in size. FAP-associated FAs, particularly larger lesions, exhibited morphologic features resembling flat FAs but varied significantly in size (2 to 103 mm). Mutation analysis identified APC and KRAS mutations in all flat FAs but never in raspberry-like FAs. Remarkably, somatic APC and KRAS mutations were also detected in 19 (63%) and 27 (90%) of FAP-associated FAs, respectively. This indicates that they are genetically equivalent to sporadic, flat FAs. This study showed that sporadic FA includes at least 2 morphologically and genetically distinct subtypes: flat and raspberry-like FA. Furthermore, flat FA represents a sporadic counterpart of FAP-associated FA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma

Masaya Yotsukura, Yuji Muraoka, Yukihiro Yoshida, Kazuo Nakagawa, Kouya Shiraishi, Takashi Kohno, Yasushi Yatabe, Shun-ichi Watanabe

Summary: This study found that the prognosis and survival of lung cancer patients after 5 years of surgery were associated with age rather than stage classification. It suggests that the long-term follow-up strategy does not need to be modified based on stage classification, and screening for secondary primary lung cancer should be considered.

ANNALS OF SURGICAL ONCOLOGY (2023)

Letter Pathology

KLF4 c.A1322C Mutation Is a Consistent and Specific Genetic Feature of Raspberry-like Foveolar-type Adenoma of the Stomach

Tomoaki Naka, Taiki Hashimoto, Teruhiko Yoshida, Yasushi Yatabe, Shigeki Sekine

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2023)

Editorial Material Oncology

ASO Visual Abstract: Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma

Masaya Yotsukura, Yuji Muraoka, Yukihiro Yoshida, Kazuo Nakagawa, Kouya Shiraishi, Takashi Kohno, Yasushi Yatabe, Shun-ichi Watanabe

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I non-small-cell lung cancer

Takaki Akamine, Masaya Yotsukura, Yukihiro Yoshida, Kazuo Nakagawa, Yasushi Yatabe, Shun-ichi Watanabe

Summary: In this study, we found that segmentectomy is a feasible procedure with comparable safety outcomes and better surgical margins and cancer control than wedge resection, particularly for clinical stage IA2 NSCLC. Segmentectomy significantly improved the recurrence-free survival compared with wedge resection, especially for patients with clinical stage IA. Subgroup analysis also demonstrated that segmentectomy had better recurrence-free survival in clinical stage IA2 and pure-solid tumors compared to wedge resection.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2023)

Article Hematology

Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases

Takanori Fukuta, Takashi Tanaka, Taiki Hashimoto, Kenji Isahaya, Yuko Kubo, Yoshihisa Yamano, Kaishi Satomi, Nobuyoshi Hiraoka, Nami Shirakawa, Ayumu Arakawa, Chitose Ogawa, Nao Nishimura, Jun Aoki, Ayumu Ito, Yoshihiro Inamoto, Sung-Won Kim, Takahiro Fukuda

Summary: Nelarabine is an effective treatment for T-cell acute lymphoblastic leukemia/lymphoma, but myelopathy is a rare but serious adverse event associated with this drug. This study reported three cases of myelopathy in patients who received nelarabine, and despite treatment, two patients died. These cases revealed the pathophysiological features of nelarabine-induced myelopathy and suggested that allogeneic hematopoietic cell transplantation may worsen the condition.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2023)

Article Medicine, General & Internal

Impact of age for overall survival in head and neck sarcoma

Hidenori Suzuki, Gaku Takano, Satoshi Tsukushi, Masashi Ando, Yasushi Yatabe, Takeshi Kodaira, Daisuke Nishikawa, Shintaro Beppu, Yasuhisa Hasegawa, Nobuhiro Hanai

Summary: The present study aimed to investigate the relationship between age at surgery and survival outcomes in patients with sarcoma in the head and neck. A total of 26 patients who underwent surgery for head and neck sarcoma from 2003 to 2017 were included. Patients who did not receive chemotherapy were significantly older at the time of surgery. Receiver operating curve analysis determined 55 years as the cutoff age for predicting death. Older age was associated with shorter overall, disease-specific, local recurrence-free, and disease-free survival rates. Multivariate analysis using Cox's proportional hazards model adjusted for chemotherapy (absence/presence) showed that age (>= 55 years/<55 years) was correlated with shorter overall survival. In conclusion, older age predicts worse overall survival in patients with head and neck sarcoma.

MEDICINE (2023)

Article Pathology

A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor

Hirotake Fujii, Yosuke Yamada, Kentaro Yamamura, Yoshihiro Ishida, Marina Tsujimura, Kazuhisa Matsumoto, Satona Tanaka, Hiroshi Date, Tadaaki Nishikawa, Yukihiro Yoshida, Jumpei Kashima, Yasushi Yatabe, Seishi Ogawa, Alexander Marx, Thomas M. Ulbright, Hironori Haga

Summary: VMT is a new type of tumor that occurs in mediastinal germ cell tumors after chemotherapy, characterized by abnormal vessels. Patients with VMT in residual tumors have an increased risk of developing sarcomas or hematopoietic malignancies.

VIRCHOWS ARCHIV (2023)

Article Multidisciplinary Sciences

Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts

Takahiko Ito, Daisuke Takayanagi, Shigeki Sekine, Taiki Hashimoto, Yoko Shimada, Maiko Matsuda, Masayoshi Yamada, Ryuji Hamamoto, Tomoyasu Kato, Dai Shida, Yukihide Kanemitsu, Narikazu Boku, Takashi Kohno, Atsuo Takashima, Kouya Shiraishi

Summary: This study compared the genetic backgrounds and clinical outcomes of Japanese and Caucasian patients with ASCC. Among 41 ASCC patients, 34 were HPV-positive and 38 were p16-positive. p16-positive patients showed better response to CCRT. The mutation profiles of ASCC were similar between Japanese and Caucasian patients, with HPV 16 genotype and PIK3CA mutations being common regardless of ethnicity. The p16 status of Japanese patients with ASCC may serve as a prognostic biomarker for CCRT.

SCIENTIFIC REPORTS (2023)

Review Oncology

KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing

Tony Kiat Hon Lim, Ferdinandos Skoulidis, Keith M. Kerr, Myung-Ju Ahn, Joshua R. Kapp, Fernando A. Soares, Yasushi Yatabe

Summary: KRAS is the most commonly mutated oncogene in advanced NSCLC, and the approval of KRAS G12C-selective inhibitors has made it a druggable target. Real-world evidence shows geographic differences in KRAS G12C prevalence, and co-mutations with other genes are also common. Testing and reporting of KRAS G12C should be included in routine biomarker testing before first-line therapy.

LUNG CANCER (2023)

Article Gastroenterology & Hepatology

A discrimination model by machine learning to avoid gastrectomy for early gastric cancer

Tsutomu Hayashi, Ken Takasawa, Takaki Yoshikawa, Taiki Hashimoto, Shigeki Sekine, Takeyuki Wada, Yukinori Yamagata, Haruhisa Suzuki, Seiichirou Abe, Shigetaka Yoshinaga, Yutaka Saito, Nobuji Kouno, Ryuji Hamamoto

Summary: This study developed a discrimination model using machine learning to select patients with early gastric cancer who do not require surgery. Data from 382 patients who received gastrectomy and 140 patients who underwent endoscopic resection followed by gastrectomy were used to develop and validate the model. The discrimination model accurately identified patients with no risk of lymph node metastasis, providing valuable information for clinical decision-making.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2023)

Article Cardiac & Cardiovascular Systems

Role of fluorine-18-fluorodeoxyglucose positron emission tomography in selecting candidates for a minimally invasive approach for thymic epithelial tumour resection

Takaki Akamine, Kazuo Nakagawa, Kimiteru Ito, Hirokazu Watanabe, Masaya Yotsukura, Yukihiro Yoshida, Yasushi Yatabe, Masahiko Kusumoto, Shun-Ichi Watanabe

Summary: We evaluated the potential of preoperative fluorine-18-fluorodeoxyglucose positron emission tomography to predict invasive thymic epithelial tumours in patients with computed tomography-defined clinical stage I thymic epithelial tumours <5 cm in size who are generally considered to be candidates for minimally invasive approaches.

INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY (2023)

Review Cell Biology

Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists

Keith M. Kerr, Lukas Bubendorf, Fernando Lopez-Rios, Farah Khalil, Sinchita Roy-Chowdhuri, Philippe Joubert, Arndt Hartmann, Elena Guerini-Rocco, Yasushi Yatabe, Paul Hofman, Wendy A. Cooper, Sanja Dacic

Summary: Many patients with non-small cell lung cancer do not receive guideline-recommended, biomarker-directed therapy. Optimized tissue management is crucial for the protection and utilization of limited tissue resources, enabling accurate molecular profiling and treatment selection.

HISTOPATHOLOGY (2023)

Review Oncology

Rare but clinically important salivary gland-type tumor of the lung: A review

Shinkichi Takamori, Yasushi Yatabe, Atsushi Osoegawa, Keiju Aokage, Hiroshige Yoshioka, Tomohiro Miyoshi, Takahiro Mimae, Makoto Endo, Aritoshi Hattori, Masaya Yotsukura, Tetsuya Isaka, Mitsuhiro Isaka, Tomohiro Maniwa, Ryu Nakajima, Shun-ichi Watanabe, Lung Canc Surgical Study Grp LCSSG, Japan Clinical Oncology Grp JCOG

Summary: Salivary gland-type lung tumors (SGT), primarily mucoepidermoid carcinoma and adenoid cystic carcinoma, are rare and present with symptoms of bronchial obstruction. Surgical resection with lymphadenectomy is recommended, and radiation therapy varies by subtype. The diagnosis and treatment of SGT remain challenging.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Cell Biology

Molecular pathology of non-small cell carcinoma

Yasushi Yatabe

Summary: Currently, lung cancer treatment involves multiple therapeutic options, including molecular-targeted therapy and immune check-point inhibitors. The efficacy of these treatments varies based on the molecular pathogenesis of lung cancer and the characteristics of different subtypes.

HISTOPATHOLOGY (2023)

暂无数据